Global Autism Spectrum Disorder Therapeutics Market, by Drug Type (Balovaptan, Aripiprazole, Melatonin, Bumetanide, CM-AT, and Risperidone), by Age Group (Adult and Child), by Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa) had a market valuation of US$ 2,285.5 million in 2019 and is forecast to grow at a CAGR of 10.9 percent during the forecast period (2019 – 2027).
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/2643
A significant factor driving the development of the global autism spectrum disorder therapeutics market is increased experimental testing and investment support for pharmacogenomics-based drug discovery. Various groups are concentrating their efforts on obtaining permits to study new medications for the treatment of ASD. The US Food and Drug Administration (FDA) awarded breakthrough therapy status to Roche’s investigational oral medication balovaptan, a vasopressin 1a receptor antagonist for people with ASD, in January 2018. In people with ASD, balovaptan showed promise in terms of improving social engagement and contact. Likewise, the US FDA granted Yamo Pharmaceuticals’ investigational drug L1-79, a tyrosine hydroxylase inhibitor designed to reduce socialization and coordination symptoms in people with ASD, fast track status in May 2018. L1-79 showed promise in treating key ASD symptoms, which is a patient need that is still unmet.
Increased support for ASD drug discovery is projected to boost the market size for ASD therapeutics. The Institute of Psychiatry, Psychology & Neuroscience at King’s College London and F. Hoffmann-La Roche, Basel are academically co-leading a research grant dubbed Autism Innovative Medicine Studies-2-Trials, which received US$ 132 million in June 2018. To increase their market share, producers in the global autism spectrum disorder therapeutics market are focusing on cooperation and partnership strategies. Servier Laboratories Ltd. and Neurochlore reported in 2017 that they had signed an exclusive license agreement in Europe to produce and sell bumetanide for pediatric autism. Servier Laboratories Ltd. will produce and sell the product in Europe, while Neurochlore will keep the rights in the U.S.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/2643
In addition, government agencies are focusing on holding seminars for parents and guardians with children with developmental disabilities, which is expected to help in the growth of the global autism spectrum disorder therapeutic market. Every year in August in Buenos Aires, Argentina, a workshop co-hosted by the Pan American Health Organization, the World Health Organization, and Autism Speaks aims to teach skills and increase awareness of autism and its prevention.
Key Takeaways
Due to rising medication approvals, investigational trials, and investment, the global autism spectrum disorder therapeutics market is projected to develop at a CAGR of 10.9 percent from 2019 to 2027.
Due to increased demand of generic Aripiprazole, the Aripiprazole market is projected to have the highest market share of drug types in 2019-2027. The U.S. Food and Drug Administration (FDA) licenced Alembic, Hetero Labs, Teva, and Torrent Pharmaceuticals to manufacture the generic form of Bristol-Myers Squibb’s Abilify oral tablets in April 2015.
Major companies contributing in the global autism spectrum disorder therapeutics market are Oryzon Genomics S.A., Curemark LLC, Yamo Pharmaceuticals LLC, Otsuka Holdings Co. Ltd., Stalicla SA., Neurim Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb, Pfizer, Inc., Novartis AG, Zynerba Pharmaceuticals Inc., Servier Laboratories Ltd., Teva Pharmaceutical Industries Ltd., and GW Pharmaceuticals Plc.
Reasons to Purchase this Report
• Current and future of global Autism Spectrum Disorder Therapeutics market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Landscape
- Collaborations & Partnerships
- Epidemiology Analysis
- Pipeline Analysis & Approved Product Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Market Dynamics
- Global Autism Spectrum Disorder Therapeutics Market, By Drug Class, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Aripiprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Risperidone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Melatonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- CM-AT
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Bumetanide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Balovaptan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Autism Spectrum Disorder Therapeutics Market, By Age Group, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Child
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Autism Spectrum Disorder Therapeutics Market, By Distribution Channel, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Autism Spectrum Disorder Therapeutics Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Canada
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- U.S.
- Europe
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Germany
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Italy
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- France
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Spain
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Russia
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Rest of Europe
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- U.K.
- Asia Pacific
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Japan
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- India
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- ASEAN
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Australia
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- South Korea
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Rest of Asia Pacific
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- China
- Latin America
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Mexico
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Argentina
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Rest of Latin America
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Brazil
- Africa
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Central Africa
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- South Africa
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- North Africa
- Middle East
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Israel
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Rest of Middle East
- Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
- Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- GCC
- Introduction
- Competitive Landscape
- Company Profiles
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Neurim Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Yamo Pharmaceuticals LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Servier Laboratories Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Otsuka Holdings Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Curemark LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Oryzon Genomics S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GW Pharmaceuticals Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Zynerba Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- STALICLA SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bristol Myers Squibb
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- F. Hoffmann-La Roche AG
- Analyst Views
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
